265 related articles for article (PubMed ID: 33069797)
21. Platelets promote breast cancer cell MCF-7 metastasis by direct interaction: surface integrin α2β1-contacting-mediated activation of Wnt-β-catenin pathway.
Zuo XX; Yang Y; Zhang Y; Zhang ZG; Wang XF; Shi YG
Cell Commun Signal; 2019 Nov; 17(1):142. PubMed ID: 31699102
[TBL] [Abstract][Full Text] [Related]
22. EpCAM-independent isolation of circulating tumor cells with epithelial-to-mesenchymal transition and cancer stem cell phenotypes using ApoStream® in patients with breast cancer treated with primary systemic therapy.
Le Du F; Fujii T; Kida K; Davis DW; Park M; Liu DD; Wu W; Chavez-MacGregor M; Barcenas CH; Valero V; Tripathy D; Reuben JM; Ueno NT
PLoS One; 2020; 15(3):e0229903. PubMed ID: 32214335
[TBL] [Abstract][Full Text] [Related]
23. Ectopic Expression of miR-147 Inhibits Stem Cell Marker and Epithelial-Mesenchymal Transition (EMT)-Related Protein Expression in Colon Cancer Cells.
Ning X; Wang C; Zhang M; Wang K
Oncol Res; 2019 Mar; 27(4):399-406. PubMed ID: 29426374
[TBL] [Abstract][Full Text] [Related]
24. TNF-α derived from M2 tumor-associated macrophages promotes epithelial-mesenchymal transition and cancer stemness through the Wnt/β-catenin pathway in SMMC-7721 hepatocellular carcinoma cells.
Chen Y; Wen H; Zhou C; Su Q; Lin Y; Xie Y; Huang Y; Qiu Q; Lin J; Huang X; Tan W; Min C; Wang C
Exp Cell Res; 2019 May; 378(1):41-50. PubMed ID: 30844387
[TBL] [Abstract][Full Text] [Related]
25. Abnormally elevated USP37 expression in breast cancer stem cells regulates stemness, epithelial-mesenchymal transition and cisplatin sensitivity.
Qin T; Li B; Feng X; Fan S; Liu L; Liu D; Mao J; Lu Y; Yang J; Yu X; Zhang Q; Zhang J; Song B; Li M; Li L
J Exp Clin Cancer Res; 2018 Nov; 37(1):287. PubMed ID: 30482232
[TBL] [Abstract][Full Text] [Related]
26. Programmed death ligand 1 regulates epithelial-mesenchymal transition and cancer stem cell phenotypes in hepatocellular carcinoma through the serum and glucocorticoid kinase 2/β-catenin signaling pathway.
Kong X; Peng H; Liu P; Fu X; Wang N; Zhang D
Cancer Sci; 2023 Jun; 114(6):2265-2276. PubMed ID: 36751987
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
[TBL] [Abstract][Full Text] [Related]
28. Tumour suppressor EP300, a modulator of paclitaxel resistance and stemness, is downregulated in metaplastic breast cancer.
Asaduzzaman M; Constantinou S; Min H; Gallon J; Lin ML; Singh P; Raguz S; Ali S; Shousha S; Coombes RC; Lam EW; Hu Y; Yagüe E
Breast Cancer Res Treat; 2017 Jun; 163(3):461-474. PubMed ID: 28341962
[TBL] [Abstract][Full Text] [Related]
29. Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer.
Li G; Su Q; Liu H; Wang D; Zhang W; Lu Z; Chen Y; Huang X; Li W; Zhang C; He Y; Fu L; Bi J
Int J Biol Sci; 2018; 14(3):280-293. PubMed ID: 29559846
[TBL] [Abstract][Full Text] [Related]
30. Emodin reduces Breast Cancer Lung Metastasis by suppressing Macrophage-induced Breast Cancer Cell Epithelial-mesenchymal transition and Cancer Stem Cell formation.
Liu Q; Hodge J; Wang J; Wang Y; Wang L; Singh U; Li Y; Yao Y; Wang D; Ai W; Nagarkatti P; Chen H; Xu P; Murphy EA; Fan D
Theranostics; 2020; 10(18):8365-8381. PubMed ID: 32724475
[TBL] [Abstract][Full Text] [Related]
31. Oncostatin-M promotes phenotypic changes associated with mesenchymal and stem cell-like differentiation in breast cancer.
West NR; Murray JI; Watson PH
Oncogene; 2014 Mar; 33(12):1485-94. PubMed ID: 23584474
[TBL] [Abstract][Full Text] [Related]
32. Fentanyl Promotes Breast Cancer Cell Stemness and Epithelial-Mesenchymal Transition by Upregulating α1, 6-Fucosylation via Wnt/β-Catenin Signaling Pathway.
Yang HF; Yu M; Jin HD; Yao JQ; Lu ZL; Yabasin IB; Yan Q; Wen QP
Front Physiol; 2017; 8():510. PubMed ID: 28798691
[TBL] [Abstract][Full Text] [Related]
33. Co-treatment with vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer.
Choi J; Park J; Cho I; Sheen Y
Radiol Oncol; 2022 Apr; 56(2):185-197. PubMed ID: 35390248
[TBL] [Abstract][Full Text] [Related]
34. The heparan sulfate proteoglycan syndecan-1 regulates colon cancer stem cell function via a focal adhesion kinase-Wnt signaling axis.
Kumar Katakam S; Tria V; Sim WC; Yip GW; Molgora S; Karnavas T; Elghonaimy EA; Pelucchi P; Piscitelli E; Ibrahim SA; Zucchi I; Reinbold R; Greve B; Götte M
FEBS J; 2021 Jan; 288(2):486-506. PubMed ID: 32367652
[TBL] [Abstract][Full Text] [Related]
35. Deglycosylation of epithelial cell adhesion molecule affects epithelial to mesenchymal transition in breast cancer cells.
Liu X; Yang L; Zhang D; Liu T; Yan Q; Yang X
J Cell Physiol; 2019 Apr; 234(4):4504-4514. PubMed ID: 30246502
[TBL] [Abstract][Full Text] [Related]
36. Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway.
Wang MH; Sun R; Zhou XM; Zhang MY; Lu JB; Yang Y; Zeng LS; Yang XZ; Shi L; Xiao RW; Wang HY; Mai SJ
Cell Death Dis; 2018 Jan; 9(1):2. PubMed ID: 29305578
[TBL] [Abstract][Full Text] [Related]
37. LincK contributes to breast tumorigenesis by promoting proliferation and epithelial-to-mesenchymal transition.
Li J; Hao Y; Mao W; Xue X; Xu P; Liu L; Yuan J; Zhang D; Li N; Chen H; Zhao L; Sun Z; Luo J; Chen R; Zhao RC
J Hematol Oncol; 2019 Feb; 12(1):19. PubMed ID: 30795783
[TBL] [Abstract][Full Text] [Related]
38. Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer.
Islam SS; Mokhtari RB; Noman AS; Uddin M; Rahman MZ; Azadi MA; Zlotta A; van der Kwast T; Yeger H; Farhat WA
Mol Carcinog; 2016 May; 55(5):537-51. PubMed ID: 25728352
[TBL] [Abstract][Full Text] [Related]
39. The mitotic kinase Aurora--a promotes distant metastases by inducing epithelial-to-mesenchymal transition in ERα(+) breast cancer cells.
D'Assoro AB; Liu T; Quatraro C; Amato A; Opyrchal M; Leontovich A; Ikeda Y; Ohmine S; Lingle W; Suman V; Ecsedy J; Iankov I; Di Leonardo A; Ayers-Inglers J; Degnim A; Billadeau D; McCubrey J; Ingle J; Salisbury JL; Galanis E
Oncogene; 2014 Jan; 33(5):599-610. PubMed ID: 23334326
[TBL] [Abstract][Full Text] [Related]
40. Circulating Tumor Cells with Stemness and Epithelial-to-Mesenchymal Transition Features Are Chemoresistant and Predictive of Poor Outcome in Metastatic Breast Cancer.
Papadaki MA; Stoupis G; Theodoropoulos PA; Mavroudis D; Georgoulias V; Agelaki S
Mol Cancer Ther; 2019 Feb; 18(2):437-447. PubMed ID: 30401696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
